ALEC vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

ALEC

38.0
AI Score
VS
JBIO Wins

JBIO

48.9
AI Score

Investment Advisor Scores

ALEC

38score
Recommendation
SELL

JBIO

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ALEC JBIO Winner
Forward P/E 8.4674 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -57.8% 0.0% JBIO
Earnings Growth -86.3% 0.0% JBIO
Tradestie Score 38.0/100 48.9/100 JBIO
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD JBIO

Relative Price Performance (Last 90 Days)

ALEC 1M: -0.5% · 3M: +36.3% JBIO 1M: -22.9% · 3M: +11.3%

Current Technical Phase

ALEC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.0 · Price: $2.14

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 31

RSI (14): 31.1 · Price: $17.89

Fundamentals Snapshot

Metric ALEC JBIO
Market Cap
Forward P/E -2.9 -6.7
Trailing P/E
Revenue (TTM)
Revenue Growth -0.6% 0.0%
Gross Margin -6.2%
Operating Margin -7.3% 0.0%
EPS -1.03 -1.07
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, JBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.